Neurol (Alprazolam)

Alprazolam, a benzodiazepine that enhances GABAergic inhibition, is employed for the following clinical conditions:

• Generalized anxiety disorder: reduces excessive worry and tension in affected individuals.
• Panic disorder: decreases the frequency and severity of panic attacks.
• Short‑term anxiety relief: provides rapid symptom control during acute anxiety episodes.

• Alprazolam binds to a specific site on the γ‑aminobutyric acid type A (GABA‑A) receptor complex, acting as a positive allosteric modulator. This increases the frequency of chloride channel opening events when GABA binds, enhancing neuronal hyperpolarisation and producing a calming effect on the central nervous system. The amplified inhibitory neurotransmission reduces neuronal firing associated with anxiety and panic.

Alprazolam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Drowsiness
• Fatigue
• Dizziness
• Impaired coordination
• Memory impairment
• Headache

Serious or Rare Side Effects

• Respiratory depression
• Severe allergic reactions (e.g., rash, swelling)
• Suicidal thoughts or behavior
• Depression or worsening mood
• Dependence and withdrawal syndrome
• Seizures (especially after abrupt discontinuation)

When prescribing alprazolam, clinicians should observe the following precautions to ensure patient safety.

• Assess substance‑use history: evaluate risk of dependence before initiating therapy.
• Avoid abrupt discontinuation: taper the dose gradually to prevent withdrawal symptoms.
• Monitor respiratory function: use caution in patients with chronic lung disease or sleep apnea.
• Exercise caution in the elderly: increased susceptibility to sedation and falls.
• Pregnancy considerations: avoid use unless benefits clearly outweigh potential risks.
• Store at room temperature: keep in the original container, protect from moisture and light.

Alprazolam interacts with several medications; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid)

• Concurrent use with other central nervous system depressants (e.g., opioids, barbiturates) may cause profound sedation or respiratory depression.
• Co‑administration with potent CYP3A4 inhibitors such as ketoconazole or itraconazole can markedly increase alprazolam plasma concentrations.
• Alcohol consumption together with alprazolam can enhance central nervous system depression and impair psychomotor performance.

Moderate Interactions (Monitor Closely)

• CYP3A4 inducers like carbamazepine or phenytoin may reduce alprazolam effectiveness by lowering its blood levels.
• Selective serotonin reuptake inhibitors may increase the risk of serotonin syndrome, though this is uncommon.
• Antihistamines may add to the sedative effects of alprazolam and should be monitored.